Highest Price Target1
Lowest Price Target1
Consensus Price Target1
Analyst Rating Summary1
Buy | Overweight | Hold | Underweight | Sell |
---|---|---|---|---|
1 | 0 | 0 | 0 | 0 |
Analyst Firms Making Recommendations1
- B of A Securities
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Companhia Brasileira
What is the target price for Companhia Brasileira (CBD)?
The latest price target for Companhia Brasileira (NYSE: CBD) was reported by B of A Securities on May 4, 2022. The analyst firm set a price target for $0.00 expecting CBD to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Companhia Brasileira (CBD)?
The latest analyst rating for Companhia Brasileira (NYSE: CBD) was provided by B of A Securities, and Companhia Brasileira upgraded their buy rating.
When is the next analyst rating going to be posted or updated for Companhia Brasileira (CBD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Companhia Brasileira, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Companhia Brasileira was filed on May 4, 2022 so you should expect the next rating to be made available sometime around May 4, 2023.
Is the Analyst Rating Companhia Brasileira (CBD) correct?
While ratings are subjective and will change, the latest Companhia Brasileira (CBD) rating was a upgraded with a price target of $0.00 to $0.00. The current price Companhia Brasileira (CBD) is trading at is $0.74, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.